Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
about
Current trends in the monitoring and treatment of diabetic retinopathy in young adultsEffect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetesAdvances in diabetic retinopathy.Surgical management of diabetic retinopathy.Perivascular Progenitor Cells Derived From Human Embryonic Stem Cells Exhibit Functional Characteristics of Pericytes and Improve the Retinal Vasculature in a Rodent Model of Diabetic Retinopathy.
P2860
Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@ast
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@en
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@nl
type
label
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@ast
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@en
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@nl
prefLabel
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@ast
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@en
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@nl
P2860
P356
P1476
Ranibizumab: the first vascula ...... ent of diabetic macular edema.
@en
P2093
Kirk E Evoy
Steven R Abel
P2860
P304
P356
10.1345/APH.1S013
P407
P577
2013-05-08T00:00:00Z